AQP4 and myeloid sarcoma: Bright spotty lesions, which have been reported in 27% to 54% of patients with AQP4 antibodies–associated myelitis,22,23,24 were absent in all children with MS and MOGAD in our cohort, underscoring their utility as a distinguishing feature between these diseases.